Table of contents
Hepatitis D virus infection
What's new
Updated 2024 WHO guidelines for the diagnosis and management of hepatitis D virus infection.
Guidelines
Key sources
The following summarized guidelines for the evaluation and management of hepatitis D virus infection are prepared by our editorial team based on guidelines from the World Health Organization (WHO 2024), the European Association for the Study of the Liver (EASL 2023,2017,2016), the Kidney Disease: Improving Global Outcomes Foundation (KDIGO 2020), and the American Association for the Study of Liver Diseases ...
Show more
Screening and diagnosis
Diagnostic investigations
Indications for testing: as per WHO 2024 guidelines, consider obtaining serological testing for anti-HDV antibodies as the preferred approach to scale up access to HDV diagnosis and linkage to care in all HBsAg-positive patients.
C
Show 3 more
More topics in this section
Laboratory testing
Noninvasive assessment
Diagnostic procedures
Medical management
Setting of care: as per AASLD 2018 guidelines, consider referring patients with HDV infection to specialized centers offering access to experimental therapies for HDV infection given the limited efficacy of current therapies.
E
More topics in this section
Indications for treatment
Pegylated interferon
Bulevirtide
Nucleoside/nucleotide analogs
Surgical interventions
Specific circumstances
Pregnant patients
As per EASL 2023 guidelines:
Offer the same management of delivery in pregnant patients with HBV/HDV coinfection as in patients with HBV since HDV mother-to-child transmission is rare and prevention of HBV infection is effective at preventing hepatitis D infection.
B
Do not discourage breastfeeding in infants born to mothers with HBV/HDV coinfection, as it is safe.
D
Follow-up and surveillance
Clinical follow-up
As per EASL 2023 guidelines:
Monitor for the development of liver-related clinical events during and after treatment in patients with chronic HDV infection.
B
Obtain regular work-up for liver disease at least every 6-12 months in patients with chronic HDV infection.
B
More topics in this section
Virological monitoring
Biochemical monitoring
Imaging follow-up
Histological monitoring